Mammalian-secreted phospholipases A 2 (sPLA 2 ) form a diverse family of at least nine enzymes that hydrolyze phospholipids to release free fatty acids and lysophospholipids. We report here the cloning and characterization of human group IIF sPLA 2 (hGIIF sPLA 2 ). The full-length cDNA codes for a signal peptide of 20 amino acid followed by a mature protein of 148 amino acids containing all of the structural features of catalytically active group II sPLA 2 s. hGIIF sPLA 2 gene is located on chromosome 1 and lies within a sPLA 2 gene cluster of about 300 kbp that also contains the genes for group IIA, IIC, IID, IIE, and V sPLA 2 s. In adult tissues, hGIIF is highly expressed in placenta, testis, thymus, liver, and kidney. Finally, recombinant expression of hGIIF sPLA 2 in Escherichia coli shows that the enzyme is Ca 2؉ -dependent, maximally active at pH 7-8, and hydrolyzes phosphatidylglycerol versus phosphatidylcholine with a 15-fold preference.
Phospholipases A 2 (PLA 2 , EC 3.1.1.4) form a superfamily of enzymes that catalyze the hydrolysis of glycerophospholipids at the sn-2 position, producing free fatty acids and lysophospholipids (1) (2) (3) (4) . Many intracellular and secreted phospholipases A 2 (sPLA 2 s) have been cloned in recent years (2, 5) , and several of them are involved in a variety of physiological and pathological functions including lipid digestion, cell proliferation, production of lipid mediators of inflammation, antibacterial defense, and cancer (4, 6) .
Within the phospholipase A 2 superfamily, sPLA 2 s form a relatively homogenous family of enzymes, and they are characterized by the presence of several disulfides, an overall conserved three-dimensional structure and a common Ca 2ϩ -dependent catalytic mechanism. Five novel mouse sPLA 2 s have been cloned during the last three years (7, 8) , and the mouse sPLA 2 family now comprises 8 distinct 14-16 kDa sPLA 2 s called group IB, IIA, IIC, IID, IIE, IIF, V, and X, as well as otoconin-95, a sPLA 2 -like protein with peculiar structural properties (9, 10) . Interestingly, genes for group IIA, IIC, IID, IIE, IIF, and V sPLA 2 s all map to mouse chromosome 4, suggesting the existence of a sPLA 2 gene cluster on this chromosome (8) . Group IB, IIA, IID, IIE, V, and X sPLA 2 s, but not group IIF have been cloned from humans (11) (12) (13) . On the other hand, group IIC sPLA 2 appears as a pseudogene in humans (14) . In addition, a novel human sPLA 2 with a predicted molecular mass of 55 kDa and a central domain similar to insect group III sPLA 2 s has recently been cloned (15) , but it remains to be determined if this sPLA 2 is functional in the mouse species. Finally, another structurally distinct human sPLA 2 has very recently been cloned (16) . All mouse and human sPLA 2 s have distinct tissue distributions, suggesting that each of them exert non redundant functions that could be related to their different enzymatic properties (6, 17, 18) , and/or their binding properties to specific receptors (18 -20) .
In this paper, we report the cloning, tissue distribution and recombinant expression in Escherichia coli of human group IIF (hGIIF) sPLA 2 . Furthermore, using
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MATERIALS AND METHODS
Molecular cloning of hGIIF sPLA 2 . Searching for sPLA 2 homologs in gene databases stored at the National Center for Biotechnology using the tBLASTn sequence alignment program (21) resulted in the identification of a human genomic sequence (PAC Clone dJ169023, GenBank Accession No. AL158172) of 142,849 nucleotides containing several regions of homology with mouse group IIF sPLA 2 . A set of oligonucleotides was designed from this genomic sequence (sense primer 5Ј-ATGAAGAAGTTCTTCACCGTGGCCA-3Ј and reverse primer 5Ј-ACCCTCCTCCCGCTCTCTCTCTCAAA-3Ј) and used in RT-PCR experiments on different human cDNAs. A PCR product of the expected size was amplified from spleen, heart, and fetal lung cDNAs. Sequencing of the DNA fragments revealed complete identity with the genomic sequence after its appropriate splicing according to consensus exon-intron boundaries (22) .
Tissue distribution of human sPLA 2 s. Multiple tissue cDNA panels (Clontech, Catalog No. K1420-1 and K1421-1) were used as templates in RT-PCR experiments using primers specific for the various human sPLA 2 s. PCRs were analyzed by agarose gel electrophoresis, transferred to positively charged nylon membranes, and hybridized with specific 32 P-labeled internal oligonucleotide probes.
Recombinant expression of hGIIF sPLA 2 . The preparation of a truncated GST hGIIF sPLA2 construct, bacterial induction and preparation of sulfonated protein from inclusion bodies were carried out as previously described for mouse group IID sPLA2 (7). The hGIIF fusion protein was refolded by a rapid dilution method as follows. Sulfonated protein was dissolved to 10 mg/ml in 4 ml of 6 M guanidine-HCl, 50 mM Tris-HCl, pH 8.0, and added dropwise (ϳ1 drop per second) to 2 liters of refolding buffer (50 mM Tris-HCl, pH 8.0, 0.9 M guanidine-HCl, 10 mM CaCl 2 , 5 mM freshly added cysteine, 30% acetonitrile) with constant stirring at room temperature. Stirring was continued for a few minutes, and then the solution was allowed to sit without stirring at room temperature for ϳ2-3 days. The sPLA2 enzymatic activity was monitored with the fluorimetric assay (17) until the activity increase starts to level off. After addition of 5 mM lauryl sulfobetaine (dodecyldimethyl-3-sulfopropylammonium, inner salt) and 1 mM methionine, the protein solution was concentrated by ultrafiltration to 50 ml with a YM-10 membrane (Amicon) and dialyzed 3 times against cleavage buffer (50 mM TrisHCl, pH 8.0, 100 mM NaCl, 1 mM CaCl 2 ). Freshly made TPCKtreated trypsin (Sigma) was then added to a final concentration of 0.15 g/ml, and the mixture was incubated overnight at room temperature, leading to a ϳ200-fold increase in sPLA 2 activity. The reaction mixture was directly loaded at 3 ml/min on a Vydac 218 TP1010 C18 reverse-phase column equilibrated with solvent A (20% acetonitrile, 0.1% trifluoroacetic acid, 1 mM methionine). Elution was performed at 3 ml/min using a linear gradient (0 -6.3% B over 2 min, followed by 6.3-27.5% B over 42 min) of solvent B (100% acetonitrile, 0.1% trifluoroacetic acid, 1 mM methionine). HPLCpurified hGIIF sPLA 2 was neutralized with 2 M Tris base, 5 mM lauryl sulfobetaine was added and the sample was concentrated in a Centriprep-10 (Amicon). The protein was then dialyzed against 10 mM Tris, pH 8.0, 0.1 mM DTT, at 4°C for 1 cycle to cleave the disulfide between the cysteine in the C-terminal extension of the hGIIF sPLA 2 and free cysteine from the refolding buffer, and then against 10 mM Tris-HCl, pH 8.0 for two cycles. The approximate yield of final product per liter of E. coli culture is 3.7 mg. Concentrations of recombinant hGIIF sPLA 2 were determined by OD at 280 nm using an extinction coefficient of 10.37 calculated from the amino acid sequence. 3 H]palmitoyl-snglycero-3-phosphoglycerol, respectively (7) . Substrate specificity studies were carried out using a slightly modified assay with the fatty acid binding protein (7) . Reaction mixtures contained 30 M POPC, POPG, or POPS large unilamellar vesicles [0.1 m, prepared by extrusion as described (23)] in Hanks' balanced salt solution with 1 mM Ca 2ϩ , 1 mM Mg 2ϩ , 9.7 g fatty acid binding protein, and 1 M 11-dansyl-undecanoic acid at 37°C. Assays were calibrated by adding a known amount of oleic acid to the complete assay in the absence of enzyme.
RESULTS AND DISCUSSION
Cloning of Human Group IIF sPLA 2 Screening of nucleic sequence databases with various mouse sPLA 2 s led to the identification of a large human genomic fragment of 142849 nucleotides with several regions of homology to mouse group IIF (mGIIF) sPLA 2 (8) . It was thus likely that this genomic clone contains a complete gene with several exons and introns coding for human group IIF sPLA 2 . Based on the homology with mGIIF, a set of sense and antisense primers was designed from the genomic sequence to amplify the full-length hGIIF sPLA 2 cDNA by RT-PCR. Human cDNAs from spleen, heart and fetal lung were used, and a strong amplification was obtained with spleen cDNA. The sequences of the amplified DNA fragments were found to contain an open reading frame of 168 amino acids comprising a signal peptide of 20 residues followed by a mature protein sequence of 148 residues (Fig. 1) . This sequence is 74% identical to mGIIF sPLA 2 and contains all of the structural features of mGIIF, including the very long C-terminal extension of 23 amino acids (8) . Together, these results indicate that the 168 amino acid sequence corresponds to hGIIF sPLA 2 (Fig. 1) .
The hGIIF mature protein sequence (calculated molecular mass 15,598 Da) is the most acidic sPLA 2 identified so far in mammals, with a calculated pI of 4.51. The 23 amino acid C-terminal extension of hGIIF also appears relatively acidic, as it contains 3 glutamic acid residues and no basic residues. Furthermore, one-third (8 of 23) of the residues of this C-terminal extension are proline residues. Interestingly, these specific features appear to be conserved among species, as the mouse group IIF C-terminal sequence is also acidic and proline-rich. The odd cysteine residue found in the mGIIF sPLA 2 C-terminal extension is also conserved in the hGIIF sPLA 2 sequence. The possible involvement of these amino acids in the putative homo-or heterodimerization of group IIF sPLA 2 s remains to be determined. Four potential N-glycosylation sites were found in the mature sequence of hGIIF sPLA 2 at positions 79, 89, 110, and 134 ( Fig. 1) and only three of them (positions 79, 89, and 134) are conserved in the mGIIF sequence (8) .
An alignment of the amino acid sequences of the 7 human catalytically active group I/II/V/X sPLA 2 collection is presented in Fig. 1 , and their respective levels of identity is shown in Table 1 . hGIIF sPLA 2 contains the different residues which are conserved in all catalytically active sPLA 2 s and is particularly well-conserved with other human sPLA 2 s in the Ca 2ϩ -loop and active site domains. hGIIF sPLA 2 however shows low levels of identity with other human sPLA 2 s, and the most closely related sPLA 2 is hGIID with only 41% identity ( Table 1 ), indicating that hGIIF sPLA 2 is not an isoform of the previously cloned human sPLA 2 s. It should be noted that the highest level of identity between any two sPLA 2 s is observed between GIIA and GIIE [55% of identity in human species (Table 1) and 51% in mouse species (8) 
hGIIF sPLA 2 Gene Maps to Chromosome 1 and Belongs to a sPLA 2 Gene Cluster
We have previously reported that the six genes for mGIIA, mGIIC, mGIID, mGIIE, mGIIF, and mGV sPLA 2 s are located in the distal part of mouse chromosome 4 and most likely form a sPLA 2 gene cluster (8) . Furthermore, the genes for hGIIA, hGIIC, and hGV sPLA 2 s have also been proposed to form a gene cluster positioned between the genetic markers AFM217zc3 and AFM290vb9 (14) . Here we have taken advantage of the human genome sequencing project to show that the 6 corresponding human sPLA 2 genes are in fact located very close to each other within a DNA fragment of about 300 kbp. The organization of the sPLA 2 gene cluster is presented in Fig. 2 .
The human PAC Clone dJ169023 (GenBank No. AL158172) of 141,865 bp that contains the hGIIF gene was generated by the sequencing program of human chromosome 1, assigning the hGIIF gene to this chromosome. In addition to the hGIIF gene, this PAC clone contains also the full-length genes for hGV, hGIID, as well as the hGIIC pseudogene. The hGIIA and hGIIE genes were found to be localized on the overlapping PAC clone dJ169023 (GenBank No. AL358253) in the telomeric direction (Fig. 2) . At present, the available sequence of this PAC clone is composed of 49 unordered contigs of different lengths. Based on alignments of these different contigs with the sequence of the PAC clone AL158172, the overlapping sequence between AL158172 and AL358253 is estimated to be about 28 kbp. The relative orientation of hGIIA and hGIIE with the other sPLA 2 genes and the exact distances between hGIIA and hGIIE genes, and hGIIA and hGV genes are unknown. However, based on the full-length sequence of the mouse cosmid clone of 41,125 bp (GenBank No. AC002108) that contains the mGIIA gene and a portion of the mGV gene (24) , it is likely that the hGIIA and hGV genes are organized in a head to tail orientation and that the hGIIE gene is localized in the telomeric direction, as presented in Fig. 2 . The tissue distribution of hGIIF and other human sPLA 2 s was analyzed by RT-PCR experiments using commercial human cDNA panels. As shown in Fig. 3 , hGIIF sPLA 2 is expressed at high levels in placenta, testis, thymus, and at lower levels in heart, kidney, liver, and prostate. Very low signals are observed in skeletal muscle, pancreas, small intestine, and spleen. In the mouse species, mGIIF transcripts were detected mostly in testis but also in several other tissues (8) . In the future, it will be interesting to analyze the expression of hGIIF sPLA 2 in embryos, since high levels of mGIIF transcripts were observed at different stages of embryonic development (8) . The different patterns of expression of human sPLA 2 s presented in Fig. 3 and that previously found for hGIIE sPLA 2 (11) clearly indicate that all human sPLA 2 s including hGIIF most probably have nonredundant functions. Overall, the tissue distributions of the human sPLA 2 s resemble those previously found by Northern blot analysis (12, 13, 15) . Finally, it is interesting to note that all human sPLA 2 s are expressed in pancreas and that placenta, lung, colon and small intestine are also rich sources of sPLA 2 .
Recombinant Expression of hGIIF sPLA 2
To study the interfacial kinetic properties of hGIIF sPLA 2 , we produced this enzyme as a recombinant fusion protein in E. coli. Inclusion bodies containing hGIIF fusion protein were solubilized and reduced, and free cysteines were sulfonated. Rapid dilution of the sulfonated protein into a buffer containing 30% acetonitrile, to minimize protein aggregation, produced refolded fusion protein which displayed maximal activity after 2-3 days. The fusion protein contains a factor Xa recognition site adjacent to the N-terminal residue of mature hGIIF which could be efficiently cleaved by using Factor Xa and or trypsin. Cleaved hGIIF sPLA 2 was purified to homogeneity by chromatography on a C18 reverse phase column, and the overall yield of purified hGIIF sPLA 2 is 3.7 mg per liter of E. coli culture (data not shown).
The interfacial enzymatic properties of hGIIF sPLA 2 are summarized in Fig. 4 . The hydrolysis of phospholipid vesicles by hGIIF sPLA 2 is strictly Ca 2ϩ -dependent, as expected for a typical sPLA 2 . Using PC vesicles as substrate, the enzyme displayed a hyperbolic dependence on the concentration of Ca 2ϩ (Fig. 4A) , and an apparent KCa 2ϩ of 140 Ϯ 40 M was calculated. Figure 4B shows that the rate of hydrolysis of phosphatidylglycerol vesicles by hGIIF sPLA 2 increases with pH in the range 5-7, as expected from the deprotonation of the active site histidine residue, and then decreases slightly at pH above 7. The relative rates for the hydrolysis of POPG, The possible presence of 5Ј noncoding exons in the hGIIC, hGIID, hGIIE and hGIIF genes remains to be determined. The orientation and exact positions of the hGIIE and hGIIA genes are unknown. However, based on the sequence of the mouse cosmid KH1 (GenBank No. AC002108) that contains the mGIIA gene and a portion of the mGV gene, it is likely that the hGIIA and hGV genes are in a head to tail orientation and that the hGIIE gene is localized closer to the telomere.
FIG. 3.
Tissue distribution of the human sPLA 2 s, as determined by RT-PCR on human adult cDNA panels. The amplified products were analyzed by Southern blot as described under Materials and Methods. No amplification was observed when cDNA was omitted in the PCR (control lane).
POPS, and POPC vesicles by hGIIF sPLA 2 are compared in Fig. 4C . As for all mammalian sPLA 2 s examined so far (7, 8) , the enzymatic activity of hGIIF sPLA 2 is highest with anionic POPG vesicles, which probably reflects the relatively high affinity of all sPLA 2 s for POPG vesicles. Although hGIIF hydrolyses POPC at only ϳ6% of the rate of POPG, this enzyme is much more active on POPC vesicles than hGIIA sPLA 2 , which displays a greater than 105-fold preference for POPG versus POPC vesicles (8) . In this context, hGIIF appears more similar to hGV and hGX sPLA 2 s, which are 3-and 10-fold more active on POPG versus POPC vesicles, respectively (17) . Whether exogenous hGIIF sPLA 2 , like hGX sPLA 2 , is able to efficiently release arachidonic acid from adherent cells will be interesting to analyze in the future (17) .
In conclusion, we have reported here the cloning and recombinant expression of hGIIF sPLA 2 . This group II sPLA 2 has unique structural features including a long, proline-rich C-terminal extension with an odd cysteine, and a very low pI value. It also has a specific tissue distribution and a fairly high propensity to hydrolyze POPC versus POPG compared to the other sPLA 2 s. Furthermore, the gene for hGIIF sPLA 2 maps to chromosome 1 together with 5 other sPLA 2 genes to form a sPLA 2 gene cluster that spans about 300 kbp. Interestingly, 5 of these 6 genes code for group II enzymes and share relatively high levels of identity ( Table 1 ). The last gene coding for group V sPLA 2 is in fact also related to group II sPLA 2 genes, as group V sPLA 2 does not contain a propeptide sequence and displays higher levels of identity to group II sPLA 2 s than to group IB and X sPLA 2 s (Table 1) . It is thus likely that these 6 different genes have arisen from recent and successive gene duplication events. It should be also noted that group IIA, IIC, IID, IIE, and V sPLA 2 s are all basic enzymes while group IIF is very acidic. On the other hand, group IB and X sPLA 2 s appear more divergent in sequence and are located on different chromosomes (13) . Both contain a propeptide sequence and the group I specific disulfide bond between cysteines 11 and 77. Whether group IB, X or one of the group II-like sPLA 2 s is more related to the sPLA 2 ancestor gene of the group I/II/V/X sPLA 2 collection (5) remains however to be determined.
